TREATMENT OF AMM

Details for Australian Patent Application No. 2003271712 (hide)

Owner NOVARTIS AG

Inventors GILES, Frank

Pub. Number AU-A-2003271712

PCT Number PCT/EP03/11214

PCT Pub. Number WO2004/033042

Priority 60/417,622 10.10.02 US

Filing date 9 October 2003

Wipo publication date 4 May 2004

International Classifications

A61P 007/00 Drugs for disorders of the blood or the extracellular fluid

A61K 031/502 - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61K 031/56 - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 031/573

A61K 031/17 - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

Event Publications

22 January 2004 Complete Application Filed

  Priority application(s): 60/417,622 10.10.02 US

3 June 2004 Application Open to Public Inspection

  Published as AU-A-2003271712

7 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003271713-Ruthenium complexes as (pre)catalysts for metathesis reactions

2003271711-FUSE CIRCUIT BREAKER ASSEMBLY COMPRISING A PRINTED CIRCUIT BOARD